Feb. 17 at 10:37 PM
$DFNS (Formerly NUKK) There’s a strong case for a
$12.50 SP by the end of the year. And we should see short term recovery to
$4 to
$5 in months.
We know internal forecast is
$70M in revenue, and they’ve only guided what they have booked now which is between
$24M to
$26M. They’re currently treading at 2X guide.
If they reach to the
$70M forecast, and they trade at 5X sales which is very modest for emerging defense tech, we’re at
$12.50.
Here’s the comps for price to sales
DFNS 2X
GILT 2X
$RCAT 5X
KOPN 6X
$UMAC 12X
Anduril 30X
$ONDS 50X
PLTR 100X
DFNS currently trading at 2X sales should start to recover and go to 5X, which implies a
$5 stock price.
Other good opportunities to watch is a move up for GILT, RCAT, and KOPN. As they continue to deliver their multiples should increase.
